Literature DB >> 20305697

Role of CK1 in GSK3beta-mediated phosphorylation and degradation of snail.

Y Xu1, S-H Lee, H S Kim, N H Kim, S Piao, S-H Park, Y S Jung, J I Yook, B-J Park, N-C Ha.   

Abstract

The epithelial to mesenchymal transition (EMT) that occurs during embryonic development has begun to attract attention as a potential mechanism for tumor cell metastasis. Snail is a well-known Zn-finger transcription factor that promotes EMT by repressing E-cadherin expression. It is known that Snail is phosphorylated by GSK3beta and degraded by beta-TrCP-mediated ubiquitination. Here we described another protein kinase, CK1, whose phosphorylation of Snail is required for the subsequent GSK3beta phosphorylation. Specific inhibition or depletion of CK1varepsilon inhibits the phosphorylation and degradation of Snail and promotes cell migration, suggesting a central role of CK1varepsilon in the EMT process. Furthermore, our study uncovered distinct roles and steps of Snail phosphorylation by CK1varepsilon and GSK3beta. Taken together, we identified CK1varepsilon as a new component of the Snail-mediated EMT process, providing insight into the mechanism of human cancer metastasis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20305697     DOI: 10.1038/onc.2010.77

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  31 in total

1.  Snail1 is stabilized by O-GlcNAc modification in hyperglycaemic condition.

Authors:  Sang Yoon Park; Hyun Sil Kim; Nam Hee Kim; Suena Ji; So Young Cha; Jeong Gu Kang; Ichiro Ota; Keiji Shimada; Noboru Konishi; Hyung Wook Nam; Soon Won Hong; Won Ho Yang; Jürgen Roth; Jong In Yook; Jin Won Cho
Journal:  EMBO J       Date:  2010-10-19       Impact factor: 11.598

Review 2.  Therapeutic Targeting of Epithelial Plasticity Programs: Focus on the Epithelial-Mesenchymal Transition.

Authors:  Reem Malek; Hailun Wang; Kekoa Taparra; Phuoc T Tran
Journal:  Cells Tissues Organs       Date:  2017-02-20       Impact factor: 2.481

Review 3.  Regulation of the protein stability of EMT transcription factors.

Authors:  V M Díaz; R Viñas-Castells; A García de Herreros
Journal:  Cell Adh Migr       Date:  2014       Impact factor: 3.405

Review 4.  Regulatory networks defining EMT during cancer initiation and progression.

Authors:  Bram De Craene; Geert Berx
Journal:  Nat Rev Cancer       Date:  2013-02       Impact factor: 60.716

5.  β-transducin repeat-containing E3 ubiquitin protein ligase inhibits migration, invasion and proliferation of glioma cells.

Authors:  Jun Liang; Wei-Feng Wang; Shao Xie; Xian-Li Zhang; Wei-Feng Qi; Xiu-Ping Zhou; Jin-Xia Hu; Qiong Shi; Ru-Tong Yu
Journal:  Oncol Lett       Date:  2017-07-07       Impact factor: 2.967

6.  Snail is an independent prognostic indicator for predicting recurrence and progression in non-muscle-invasive bladder cancer.

Authors:  Yuancheng Gou; Weihong Ding; Ke Xu; Hong Wang; Zhongqing Chen; Jun Tan; Guowei Xia; Qiang Ding
Journal:  Int Urol Nephrol       Date:  2014-11-12       Impact factor: 2.370

Review 7.  DEPTOR ubiquitination and destruction by SCF(β-TrCP).

Authors:  Zhiwei Wang; Jiateng Zhong; Daming Gao; Hiroyuki Inuzuka; Pengda Liu; Wenyi Wei
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-03-27       Impact factor: 4.310

Review 8.  Targeting the ubiquitin pathway for cancer treatment.

Authors:  Jia Liu; Shavali Shaik; Xiangpeng Dai; Qiong Wu; Xiuxia Zhou; Zhiwei Wang; Wenyi Wei
Journal:  Biochim Biophys Acta       Date:  2014-12-04

Review 9.  An evolving role for DEPTOR in tumor development and progression.

Authors:  Zhiwei Wang; Jiateng Zhong; Hiroyuki Inuzuka; Daming Gao; Shavali Shaik; Fazlul H Sarkar; Wenyi Wei
Journal:  Neoplasia       Date:  2012-05       Impact factor: 5.715

10.  Circadian gating of epithelial-to-mesenchymal transition in breast cancer cells via melatonin-regulation of GSK3β.

Authors:  Lulu Mao; Robert T Dauchy; David E Blask; Lauren M Slakey; Shulin Xiang; Lin Yuan; Erin M Dauchy; Bin Shan; George C Brainard; John P Hanifin; Tripp Frasch; Tamika T Duplessis; Steven M Hill
Journal:  Mol Endocrinol       Date:  2012-09-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.